GTN Infusion Dosing and Titration

Initial Dosing Strategy

The American College of Cardiology and European Society of Cardiology recommend starting intravenous nitroglycerin at 10 mcg/min and increasing by 10 mcg/min every 3-5 minutes until symptoms resolve or blood pressure responds, with a commonly used ceiling of 200 mcg/min, for patients with acute heart failure or other conditions requiring vasodilation 1, 2
The European Society of Cardiology recommends an alternative starting range of 10-20 mcg/min for acute heart failure patients, with careful monitoring of blood pressure and clinical response 3, 4

Increase the dose by 10 mcg/min every 3-5 minutes for the first 20 minutes until symptom relief or blood pressure response occurs, then adjust the increment size and interval based on clinical response, according to the American Heart Association and European Society of Cardiology 1, 2
If no response at 20 mcg/min, use larger increments of 10 mcg/min, then advance to 20 mcg/min increments, with close monitoring of blood pressure and clinical response 1, 2

The commonly recommended ceiling is 200 mcg/min, though this is not an absolute limit, and doses up to 300-400 mcg/min have been safely administered for 2-4 weeks without increasing methemoglobin levels, according to the American College of Cardiology 1, 2

Do not initiate GTN infusion if systolic BP <90 mmHg or >30 mmHg below baseline, and target systolic BP should not fall below 110 mmHg in normotensive patients, according to the American Heart Association and European Society of Cardiology 1, 2
In acute heart failure, GTN is recommended for patients with systolic BP >110 mmHg and may be used cautiously between 90-110 mmHg, with frequent blood pressure monitoring, according to the European Society of Cardiology 3, 4

Phosphodiesterase-5 inhibitor use within 24 hours (sildenafil) or 48 hours (tadalafil) is an absolute contraindication due to risk of profound hypotension, MI, and death, according to the American College of Cardiology and European Society of Cardiology 1, 2

Tolerance develops after 24 hours of continuous infusion and is dose and duration dependent, necessitating incremental dosing and consideration of alternative vasodilators, according to the American College of Cardiology and European Society of Cardiology 1, 3, 4
Transition to oral/topical nitrates within 24 hours once the patient is stable and symptom-free for 12-24 hours, to prevent rebound vasoconstriction, according to the American College of Cardiology 1